GEN3014 Trial in Relapsed or Refractory Hematologic Malignancies

Clinical trial NCT04824794 · TERMINATED

Trial details

NCT number: NCT04824794
Sponsor: Genmab
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed or Refractory Multiple Myeloma (RRMM)Diffuse Large B Cell Lymphoma (DLBCL)Acute Myeloid Leukemia (AML)

Start date: 2021-03-09
Primary completion: 2025-06-30
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.